Table 1.
Initial screening data of analogs of lapatinib 1.
| |||||
|---|---|---|---|---|---|
| Compd | GSK Number | R1 | R2 | R3 | Tbb EC50 (μM)a,b |
| 2 | GW58337A |
|
Cl | H | 0.41 |
| 3 | GW601906A |
|
Cl | F | 0.43 |
| 4 | GW633460A |
|
Cl | F | 0.48 |
| 5 | GW616030X |
|
Cl | F | 0.52 |
| 6 | GW615311X |
|
Cl | F | 0.55 |
| 7 | GW580496A |
|
Br | H | 0.56 |
| 8 | GW576924A |
|
F | F | 0.60 |
| 9 | GW616907X |
|
Cl | F | 1.51 |
| 1 | lapatinib |
|
Cl | F | 1.54 |
| melarsoprol49 | 0.0063 | ||||
| eflornithine50 | 16.4 | ||||
| pentamidine49 | 0.0035 | ||||
| SCYX-715851 | 0.794 | ||||
All EC50 values are ± 7%.
Concentration giving 50% inhibition of growth of T brucei brucei Lister 427 cells